Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | LPL | P06858 | 4/20 | 0.46 |
| ▸ | LIPG | Q9Y5X9 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.45 |
| ▸ | MGLL | Q99685 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 5/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2554148 | 1.00 | CYP2C9 (0.48) | CYP2C9LPLLIPGMAPTALDH1A1 | |
| SCHEMBL28639173 | 0.98 | LPL (0.47) | CYP2C9LPLLIPGMAPTALDH1A1 | |
| SCHEMBL13326212 | 0.98 | LPL (0.47) | CYP2C9LPLLIPGMAPTALDH1A1 | |
| SCHEMBL29186351 | 0.95 | CYP2C9 (0.49) | CYP2C9LPLLIPGMAPTALDH1A1 | |
| SCHEMBL2556952 | 0.95 | CYP2C9 (0.49) | CYP2C9LPLLIPGMAPTALDH1A1 | |
| SCHEMBL8113908 | 0.93 | CYP2C9 (0.46) | CYP2C9LPLLIPGMAPTALDH1A1 | |
| SCHEMBL8107212 | 0.93 | CYP2C9 (0.46) | CYP2C9LPLLIPGMAPTALDH1A1 | |
| SCHEMBL3025618 | 0.89 | CYP2C9 (0.59) | CYP2C9LPLLIPGMAPTALDH1A1 | |
| SCHEMBL6556143 | 0.89 | CYP2C9 (0.59) | CYP2C9LPLLIPGMAPTALDH1A1 | |
| SCHEMBL10579686 | 0.87 | CYP2C9 (0.54) | CYP2C9MAPTALDH1A1LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4280882-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2023-11-29 | — | — | EP | claimed |
| CN-116916755-A | Materials and methods for extending the shelf life of food products | JP实验室公司 | 2023-10-20 | — | — | CN | claimed |
| WO-2022159439-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2022-07-28 | — | — | WO | claimed |
| US-20250376452-A1 | 17-Beta-Hydroxysteroid Dehydrogenase Type 13 Inhibitors and Methods of Use Thereof | ENANTA PHARM INC (US) | 2025-12-11 | — | — | US | disclosed |
| EP-4387603-A1 | 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS OF USE THEREOF | Enanta Pharmaceuticals, Inc. (US) | 2024-06-26 | — | — | EP | disclosed |
| CN-118103038-A | 17 Beta-hydroxysteroid dehydrogenase 13 inhibitors and methods of use thereof | 英安塔制药有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-115734973-B | Liquid crystal composition, optical element and light guide element | 富士胶片株式会社 | 2024-02-20 | — | — | CN | disclosed |
| CN-117534600-A | Isothiocyano trans-cyclohexyl biphenyl liquid crystal compound, and preparation method and application thereof | 武汉轻工大学 | 2024-02-09 | — | — | CN | disclosed |
| CN-116916755-A | Materials and methods for extending the shelf life of food products | JP实验室公司 | 2023-10-20 | — | — | CN | disclosed |
| US-20230124399-A1 | LIQUID CRYSTAL COMPOSITION, OPTICAL ELEMENT, AND LIGHT GUIDE ELEMENT | FUJIFILM CORPORATION (JP) | 2023-04-20 | — | — | US | disclosed |
| CN-115734973-A | Liquid crystal composition, optical element and light guide element | 富士胶片株式会社 | 2023-03-03 | — | — | CN | disclosed |
| WO-1995010496-A1 | 2,3,4-TRIFLUOROBENZENES AND THEIR USE IN LIQUID CRYSTAL MIXTURES | MERCK PATENT GMBH (DE) | 1995-04-20 | — | — | WO | disclosed |
| WO-1995009828-A1 | 2,4,5-TRIFLUOROBENZENES AND THEIR USE IN LIQUID CRYSTAL MIXTURES | MERCK PATENT GMBH (DE) | 1995-04-13 | — | — | WO | disclosed |
| WO-1993025529-A1 | 3-FLUOROPYRIDINES, METHOD OF PREPARING THEM AND THEIR USE IN LIQUID-CRYSTAL MIXTURES | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-12-23 | — | — | WO | disclosed |
| WO-1993025530-A2 | VINYL ARENAS HAVING RETINOID-LIKE ACTIVITY | ALLERGAN, INC. (US) | 1993-12-23 | — | — | WO | disclosed |
| EP-0573878-A1 | 3-fluoropyridines, process for their preparation and their use in liquid crystal mixtures | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-12-15 | — | — | EP | disclosed |
| EP-0513262-A1 | 3,6-DISUBSTITUTED 2-HALOPYRIDINES | MERCK PATENT GmbH (DE) | 1992-11-19 | — | — | EP | disclosed |
| WO-1992009576-A1 | 3,6-DISUBSTITUTED 2-HALOPYRIDINES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1992-06-11 | — | — | WO | disclosed |
| EP-0440762-A1 | 5-OXY-2-PHENYLPYRIDINES AND LIQUID-CRYSTAL MATERIALS. | MERCK PATENT GMBH (DE) | 1991-08-14 | — | — | EP | disclosed |
| WO-1991002722-A1 | 5-OXY-2-PHENYLPYRIDINES AND LIQUID-CRYSTAL MATERIALS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1991-03-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250376452-A1 | 17-Beta-Hydroxysteroid Dehydrogenase Type 13 Inhibitors and Methods of Use Thereof | HSD17B1, HSD17B13, HSD17B3 | CYP2C9 226/4885LPL 382/4885LIPG 435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.